title: High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults.
authors.forename: D
authors.initials: D
authors.lastname: Douer
authors.forename: A
authors.initials: A
authors.lastname: Levine
authors.forename: W F
authors.initials: WF
authors.lastname: Anderson
authors.forename: M
authors.initials: M
authors.lastname: Gordon
authors.forename: S
authors.initials: S
authors.lastname: Groshen
authors.forename: A
authors.initials: A
authors.lastname: Khan
authors.forename: A
authors.initials: A
authors.lastname: Mohrbacher
authors.forename: F
authors.initials: F
authors.lastname: Muggia
authors.forename: D
authors.initials: D
authors.lastname: Shibata
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000556:secondary / Q000628:therapy*; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005819:Genetic Markers; D005822:Genetic Vectors / Q000235:genetics; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D014161:Transduction, Genetic; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents; D005819:Genetic Markers